BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lai SW, Liao KF, Lin CL, Kuo YH, Liu CS, Hwang BF. The incidence rate of herpes zoster in inflammatory bowel disease: A meta-analysis of cohort studies. Medicine (Baltimore) 2021;100:e26863. [PMID: 34414937 DOI: 10.1097/MD.0000000000026863] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Din S, Selinger CP, Black CJ, Ford AC. Systematic review with network meta-analysis: Risk of Herpes zoster with biological therapies and small molecules in inflammatory bowel disease. Aliment Pharmacol Ther 2023;57:666-75. [PMID: 36585944 DOI: 10.1111/apt.17379] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Jun S, Jie L, Ren M, Zhihua R. Secondary Indicators for an Evaluation and Guidance System for Quality of Care in Inflammatory Bowel Disease Centers: A Critical Review of the Inflammatory Bowel Disease Quality of Care Center. Inflammatory Bowel Diseases 2022;28:S3-S8. [DOI: 10.1093/ibd/izac009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]